TDF Injuries: Viread, Truvada, Atripla, Complera and Stribild Class Action

HIV Drug Injury Lawyers Vancouver, British Columbia

On April 19, 2021, Klein Lawyers filed a class action lawsuit on behalf of all persons who were prescribed and consumed Viread, Truvada, Atripla, Complera,  and/or Stribild in Canada.  These five drugs are Tenofovir Disoproxil Fumarate (“TDF”) based medication which are used for the prevention and treatment of HIV/AIDS. 

The lawsuit alleges that the maker of these drugs, Gilead, knew that there was a safer alternative to TDF and knowingly delayed and withheld the development, marketing and sale of the alternative, to maximize their profit from sales of Viread, Truvada, Atripla, Complera and Stribild. Due to Gilead’s actions, patients in Canada were exposed to the more toxic and dangerous medication for over a decade.  As a result, Canadians unwittingly and needlessly suffered permanent, debilitating, and sometimes fatal kidney and bone damage. 

If you were prescribed the TDF based drugs – Viread, Truvada, Atripla, Complera and/or Stribild in Canada and experienced one of the following injuries linked to TDF, please fill out our Do You Qualify form:

  • Kidney damage and kidney failure, including:
    • Renal insufficiency/impairment 
    • Decreased kidney function
    • Chronic kidney disease
    • Tubular dysfunction
    • Fanconi syndrome
    • Renal failure
    • End-stage renal disease
  • Bone density loss
    • Reduced bone density
    • Bone malformation
    • Bone breaks/fractures
    • Tooth loss

If you or your loved one takes Truvada, Viread, Atripla, Complera, and/or Stribild and experienced serious side effects, Klein Lawyers can help. Please contact us via our confidential form or call (604) 874-7171 for assistance.